Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2011 2
2012 3
2013 3
2014 2
2015 2
2016 2
2017 2
2018 2
2019 4
2020 4
2021 1
2022 3
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for honglian ma
Your search for Zhonglian Ma retrieved no results
Different administration routes of recombinant human endostatin combined with concurrent chemoradiotherapy might lead to different efficacy and safety profile in unresectable stage III non-small cell lung cancer: Updated follow-up results from two phase II trials.
Honglian M, Zhouguang H, Fang P, Lujun Z, Dongming L, Yujin X, Yong B, Liming X, Yirui Z, Xiao H, Jin W, Yue K, Lvhua W, Ming C. Honglian M, et al. Thorac Cancer. 2020 Apr;11(4):898-906. doi: 10.1111/1759-7714.13333. Epub 2020 Feb 18. Thorac Cancer. 2020. PMID: 32068962 Free PMC article. Clinical Trial.
A combined predictive model based on radiomics features and clinical factors for disease progression in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy.
Yang H, Wang L, Shao G, Dong B, Wang F, Wei Y, Li P, Chen H, Chen W, Zheng Y, He Y, Zhao Y, Du X, Sun X, Wang Z, Wang Y, Zhou X, Lai X, Feng W, Shen L, Qiu G, Ji Y, Chen J, Jiang Y, Liu J, Zeng J, Wang C, Zhao Q, Yang X, Hu X, Ma H, Chen Q, Chen M, Jiang H, Xu Y. Yang H, et al. Among authors: ma h. Front Oncol. 2022 Aug 2;12:967360. doi: 10.3389/fonc.2022.967360. eCollection 2022. Front Oncol. 2022. PMID: 35982975 Free PMC article.
Final report of a prospective randomized study on thoracic radiotherapy target volume for limited-stage small cell lung cancer with radiation dosimetric analyses.
Hu X, Bao Y, Xu YJ, Zhu HN, Liu JS, Zhang L, Guo Y, Jin Y, Wang J, Ma HL, Xu XL, Song ZB, Tang HR, Peng F, Fang M, Kong Y, Chen MY, Dong BQ, Zhu L, Yu C, Yu XM, Hong W, Fan Y, Zhang YP, Chen PC, Zhao Q, Jiang YH, Zhou XM, Chen QX, Sun WY, Mao WM, Chen M. Hu X, et al. Cancer. 2020 Feb 15;126(4):840-849. doi: 10.1002/cncr.32586. Epub 2019 Nov 12. Cancer. 2020. PMID: 31714592 Free article. Clinical Trial.
HELPER study: A phase II trial of continuous infusion of endostar combined with concurrent etoposide plus cisplatin and radiotherapy for treatment of unresectable stage III non-small-cell lung cancer.
Zhai Y, Ma H, Hui Z, Zhao L, Li D, Liang J, Wang X, Xu L, Chen B, Tang Y, Wu R, Xu Y, Pang Q, Chen M, Wang L. Zhai Y, et al. Among authors: ma h. Radiother Oncol. 2019 Feb;131:27-34. doi: 10.1016/j.radonc.2018.10.032. Epub 2018 Dec 17. Radiother Oncol. 2019. PMID: 30773184 Clinical Trial.
27 results